• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Syngene International Ltd.
    23 Jul 2025
    657.25
    -2.02%
    At 87 crore, Syngene posts 61% growth in profit in Q1
    Business Line
    CFO Deepak Jain noted that the current quarter's PAT includes a tax benefit from the transfer of gratuity funds to the employee gratuity trust.
    Copy LinkShare onShare on Share on Share on
    Syngene International Ltd.'s price crossed below 50Day SMA today
    Syngene Q1 PAT up 59% to 87 crore, operational revenue rises 11%
    Business Standard | 23 Jul 2025 1 more
    Syngene International Q1 Results: Profit Rises 15%, Margin Expands
    NDTV Profit | 23 Jul 2025
    logo
    Concord Biotech Ltd.
    23 Jul 2025
    1621.20
    -2.37%
    Concord Biotech rises 2% on incorporating its arm for marketing and sales
    Business Standard
    Concord Biotech share price rose 2.3 per cent, logging an intraday high at 1941.25 per share on the BSE after the company incorporated its subsidiary Concord Lifegen
    Copy LinkShare onShare on Share on Share on
    Concord Biotech Ltd. is trading below all available SMAs
    logo
    Cipla Ltd.
    23 Jul 2025
    1559.00
    0.69%
    Cipla Q1 preview: Net profit may jump up to 4%, revenue by 8% YoY
    Business Standard
    Cipla is scheduled to announce its April-June quarter earnings for the financial year 2025-26 (Q1FY26) on Friday, July 25, 2025
    Copy LinkShare onShare on Share on Share on
    Cipla Ltd. is trading above all available SMAs
    logo
    AstraZeneca Pharma India Ltd.
    22 Jul 2025
    9016.50
    0.08%
    AstraZeneca unveils $50 bn US investment as pharma tariff threat looms
    Business Standard
    On Monday, AstraZeneca said the expansion supports its ambition to reach $80 billion in annual revenue by 2030, with half coming from the US
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 164 to 181 in Jun 2025 qtr.
    logo
    Blue Jet Healthcare Ltd
    22 Jul 2025
    Promoter Sell Dividend
    715.05
    0.17%
    Blue Jet Healthcare shares drop 10% post Q1 results; details here
    Business Standard
    At 2:30 PM, shares of Blue Jet Healthcare were trading at 906.15, down by 10 per cent on the BSE.
    Copy LinkShare onShare on Share on Share on
    Blue Jet Healthcare Ltd average weekly volume is high.
    logo
    Dr. Reddy's Laboratories Ltd.
    22 Jul 2025
    US FDA Observation
    1310.40
    0.74%
    Pharma buzz: 3 stocks set to drive action today
    Business Line
    Key triggers for Erraya Life, Dr Reddy's and Cipla
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 911 to 917 in Jun 2025 qtr.
    logo
    Cipla Ltd.
    21 Jul 2025
    1559.00
    0.69%
    Cipla buys 20% stake in iCaltech to broaden respiratory device portfolio
    Business Standard
    Cipla has acquired a 20% stake in iCaltech Innovations for Rs 5 crore, expanding its presence in the respiratory diagnostics segment with a strategic investment in medical device development
    Copy LinkShare onShare on Share on Share on
    Cipla Ltd. is trading above all available SMAs
    Cipla invests in medical devices company iCaltech Innovations
    Business Line | 21 Jul 2025
    logo
    Sun Pharmaceutical Industries Ltd.
    21 Jul 2025
    1610.50
    0.53%
    Sun Pharma's ILUMYA delivers positive psoriatic arthritis trial results
    Business Standard
    Phase 3 trials show ILUMYA improved PsA symptoms significantly, with no new safety concerns; results support potential regulatory submissions in the US and globally
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors decreased from 1351 to 1326 in Jun 2025 qtr
    logo
    Dr. Reddy's Laboratories Ltd.
    21 Jul 2025
    US FDA Observation
    1310.40
    0.74%
    Here's what brokerages expect from Dr Reddy's Labs ahead of Q1 show
    Business Standard
    Dr Reddy's Labs Q1 preview: The company's net profit is expected to come at 1,460 crore, marking around 4.9 per cent Y-o-Y increase, on average, as against 1,392.4 crore in Q1 FY25
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 911 to 917 in Jun 2025 qtr.
    logo
    SMS Pharmaceuticals Ltd.
    21 Jul 2025
    285.50
    -2.21%
    Sharda Crop, SMS Pharma among top analyst bets; check target, stop-loss
    Business Standard
    Stocks to buy today: Sharda Cropchem has seen a decisive surge, followed by some profit booking, while SMS Pharmaceuticals has experienced a gradual resurgence over the last couple of trading sessions
    Copy LinkShare onShare on Share on Share on
    SMS Pharmaceuticals Ltd. high volume past week with price gain of 16.87.
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • L T Elevator
    • TechD Cybersecurity
    • Euro Pratik Sales
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd